Literature DB >> 27531930

LysoPCs induce Hck- and PKCδ-mediated activation of PKCγ causing p47phox phosphorylation and membrane translocation in neutrophils.

Marguerite R Kelher1,2, Nathan J D McLaughlin2, Anirban Banerjee2, David J Elzi1,2, Fabia Gamboni2, Samina Y Khan3, Xianzhong Meng2, Sanchayita Mitra2, Christopher C Silliman4,2,3.   

Abstract

Lysophosphatidylcholines (lysoPCs) are effective polymorphonuclear neutrophil (PMN) priming agents implicated in transfusion-related acute lung injury (TRALI). LysoPCs cause ligation of the G2A receptor, cytosolic Ca2+ flux, and activation of Hck. We hypothesize that lysoPCs induce Hck-dependent activation of protein kinase C (PKC), resulting in phosphorylation and membrane translocation of 47 kDa phagocyte oxidase protein (p47phox). PMNs, human or murine, were primed with lysoPCs and were smeared onto slides and examined by digital microscopy or separated into subcellular fractions or whole-cell lysates. Proteins were immunoprecipitated or separated by polyacrylamide gel electrophoresis and immunoblotted for proteins of interest. Wild-type (WT) and PKCγ knockout (KO) mice were used in a 2-event model of TRALI. LysoPCs induced Hck coprecipitation with PKCδ and PKCγ and the PKCδ:PKCγ complex also had a fluorescence resonance energy transfer (FRET)+ interaction with lipid rafts and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 (WAVE2). PKCγ then coprecipitated with p47phox Immunoblotting, immunoprecipitation (IP), specific inhibitors, intracellular depletion of PKC isoforms, and PMNs from PKCγ KO mice demonstrated that Hck elicited activation/Tyr phosphorylation (Tyr311 and Tyr525) of PKCδ, which became Thr phosphorylated (Thr507). Activated PKCδ then caused activation of PKCγ, both by Tyr phosphorylation (Τyr514) and Ser phosphorylation, which induced phosphorylation and membrane translocation of p47phox In PKCγ KO PMNs, lysoPCs induced Hck translocation but did not evidence a FRET+ interaction between PKCδ and PKCγ nor prime PMNs. In WT mice, lysoPCs served as the second event in a 2-event in vivo model of TRALI but did not induce TRALI in PKCγ KO mice. We conclude that lysoPCs prime PMNs through Hck-dependent activation of PKCδ, which stimulates PKCγ, resulting in translocation of phosphorylated p47phox. © Society for Leukocyte Biology.

Entities:  

Keywords:  WAVE; acute lung injury; lipid rafts

Mesh:

Substances:

Year:  2016        PMID: 27531930      PMCID: PMC5166440          DOI: 10.1189/jlb.3A0813-420RRR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  83 in total

1.  Synergistic control of protein kinase Cgamma activity by ionotropic and metabotropic glutamate receptor inputs in hippocampal neurons.

Authors:  Franca Codazzi; Alessandra Di Cesare; Nino Chiulli; Alberto Albanese; Tobias Meyer; Daniele Zacchetti; Fabio Grohovaz
Journal:  J Neurosci       Date:  2006-03-29       Impact factor: 6.167

2.  Control of astrocyte Ca(2+) oscillations and waves by oscillating translocation and activation of protein kinase C.

Authors:  F Codazzi; M N Teruel; T Meyer
Journal:  Curr Biol       Date:  2001-07-24       Impact factor: 10.834

3.  Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium.

Authors:  Christopher C Silliman; David J Elzi; Daniel R Ambruso; Rene J Musters; Christine Hamiel; Ronald J Harbeck; Andrew J Paterson; A Jason Bjornsen; Travis H Wyman; Marguerite Kelher; Kelly M England; Nathan McLaughlin-Malaxecheberria; Carlton C Barnett; Junichi Aiboshi; Anirban Bannerjee
Journal:  J Leukoc Biol       Date:  2003-04       Impact factor: 4.962

4.  Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly.

Authors:  F R DeLeo; J Renee; S McCormick; M Nakamura; M Apicella; J P Weiss; W M Nauseef
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

5.  Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors.

Authors:  T Murohara; R Scalia; A M Lefer
Journal:  Circ Res       Date:  1996-05       Impact factor: 17.367

6.  Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.

Authors:  Minoru Narita; Hirokazu Mizoguchi; Junaidi Khotib; Masami Suzuki; Satoru Ozaki; Yoshinori Yajima; Michiko Narita; Leon F Tseng; Tsutomu Suzuki
Journal:  Neurosci Lett       Date:  2002-10-04       Impact factor: 3.046

7.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis.

Authors:  Ji-Jing Yan; Jun-Sub Jung; Jung-Eun Lee; Jongho Lee; Sung-Oh Huh; Hee-Sung Kim; Kyeong Cheon Jung; Jae-Young Cho; Ju-Suk Nam; Hong-Won Suh; Yung-Hi Kim; Dong-Keun Song
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

8.  Protein kinase C-gamma activation in the early streptozotocin diabetic rat lens.

Authors:  Dingbo Lin; Richie Harris; Rachael Stutzman; Guido A Zampighi; Harriett Davidson; Dolores J Takemoto
Journal:  Curr Eye Res       Date:  2007-06       Impact factor: 2.424

9.  Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation.

Authors:  D L Marquardt; L L Walker
Journal:  J Allergy Clin Immunol       Date:  1991-11       Impact factor: 10.793

10.  An actin-based wave generator organizes cell motility.

Authors:  Orion D Weiner; William A Marganski; Lani F Wu; Steven J Altschuler; Marc W Kirschner
Journal:  PLoS Biol       Date:  2007-09       Impact factor: 8.029

View more
  6 in total

1.  Supernatants and lipids from stored red blood cells activate pulmonary microvascular endothelium through the BLT2 receptor and protein kinase C activation.

Authors:  Christopher C Silliman; Marguerite R Kelher; Samina Y Khan; F Bernadette West; Nathan J D McLaughlin; David J Elzi; Kelly England; Jason Bjornsen; Susan A Kuldanek; Anirban Banerjee
Journal:  Transfusion       Date:  2017-09-06       Impact factor: 3.157

2.  Lysophosphatidylcholine induces cyclooxygenase-2-dependent IL-6 expression in human cardiac fibroblasts.

Authors:  Hui-Ching Tseng; Chih-Chung Lin; Chen-Yu Wang; Chien-Chung Yang; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Cell Mol Life Sci       Date:  2018-09-18       Impact factor: 9.261

3.  RNA sequencing of mesenchymal stem cells reveals a blocking of differentiation and immunomodulatory activities under inflammatory conditions in rheumatoid arthritis patients.

Authors:  Jose Ramon Lamas; Benjamin Fernandez-Gutierrez; Arkaitz Mucientes; Fernando Marco; Yaiza Lopiz; Juan Angel Jover; Lydia Abasolo; Luis Rodríguez-Rodríguez
Journal:  Arthritis Res Ther       Date:  2019-05-06       Impact factor: 5.156

4.  Lysophosphatidylcholine induces azurophil granule translocation via Rho/Rho kinase/F-actin polymerization in human neutrophils.

Authors:  Hwa-Yong Ham; Shin-Hae Kang; Dong-Keun Song
Journal:  Korean J Physiol Pharmacol       Date:  2022-05-01       Impact factor: 2.016

5.  Succinate Activation of SUCNR1 Predisposes Severely Injured Patients to Neutrophil-Mediated ARDS.

Authors:  Geoffrey R Nunns; Navin Vigneshwar; Marguerite R Kelher; Gregory R Stettler; Lajos Gera; Julie A Reisz; Angelo D'Alessandro; Joshua Ryon; Kirk C Hansen; Fabia Gamboni; Ernest E Moore; Erik D Peltz; Mitchell J Cohen; Kenneth L Jones; Angela Sauaia; Xiayuan Liang; Anirban Banerjee; Arsen Ghasabyan; James G Chandler; Sophia Rodawig; Carter Jones; Andrew Eitel; Patrick Hom; Christopher C Silliman
Journal:  Ann Surg       Date:  2020-11-18       Impact factor: 12.969

6.  The lysophospholipid-binding molecule CD1D is not required for the alloimmunization response to fresh or stored RBCs in mice despite RBC storage driving alterations in lysophospholipids.

Authors:  Jelena Medved; Brittney M Knott; Soraya N Tarrah; Andria N Li; Neha Shah; Tamara C Moscovich; Alexis R Boscia; Juan E Salazar; Manjula Santhanakrishnan; Jeanne E Hendrickson; Xiaoyun Fu; James C Zimring; Chance John Luckey
Journal:  Transfusion       Date:  2021-06-28       Impact factor: 3.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.